2022
DOI: 10.1016/j.microc.2022.107860
|View full text |Cite
|
Sign up to set email alerts
|

Time of Flight Secondary Ion Mass Spectrometry imaging for precise localization of zirconium-labelled trastuzumab in xenograft cancer tumour tissues

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
1

Citation Types

0
1
0

Year Published

2024
2024
2024
2024

Publication Types

Select...
2

Relationship

0
2

Authors

Journals

citations
Cited by 2 publications
(1 citation statement)
references
References 18 publications
0
1
0
Order By: Relevance
“…The results revealed accumulation of iron in mitochondria, lysosomes and vacuole-like organelles, with SIMS providing more in-depth chemical data, providing insights into Fe metabolism at the cellular level. Penen et al 187 utilised TOF-SIMS imaging to investigate the distribution of the cancer drug trastuzumab which is used for tumours with high levels of human epidermal growth factor receptor 2 (HER2) present, such as ovarian and breast cancers. Mouse models were exposed to Zr-labelled trastuzumab and sacrificed 3 days after exposure, with tumours extracted, frozen at −80 °C and sectioned.…”
Section: Applications: Clinical and Biological Materialsmentioning
confidence: 99%
“…The results revealed accumulation of iron in mitochondria, lysosomes and vacuole-like organelles, with SIMS providing more in-depth chemical data, providing insights into Fe metabolism at the cellular level. Penen et al 187 utilised TOF-SIMS imaging to investigate the distribution of the cancer drug trastuzumab which is used for tumours with high levels of human epidermal growth factor receptor 2 (HER2) present, such as ovarian and breast cancers. Mouse models were exposed to Zr-labelled trastuzumab and sacrificed 3 days after exposure, with tumours extracted, frozen at −80 °C and sectioned.…”
Section: Applications: Clinical and Biological Materialsmentioning
confidence: 99%